Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/06/2003US20030207913 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
11/06/2003US20030207911 For treatment of disease associated with the adenosine A2 receptor such as Alzheimer's disease and Parkinson's disease
11/06/2003US20030207910 Treatment of HIV and AIDS
11/06/2003US20030207909 Therapeutic acridone and acridine compounds
11/06/2003US20030207908 Systemically and topically treat bacterial Gram-positive, Gram-negative and anaerobic infections, specially resistant Gram-positive mycobacterial infections and emerging nosocomlal pathogen infections
11/06/2003US20030207907 Deliverying antirestenoic compound such as an antiproliferative, immunosuppressive, or antiinflammatory drug, particularly rapamycin, tacrolimus, paclitaxel, dexamethasone, or an active analog or derivative thereof
11/06/2003US20030207906 Chemical compounds
11/06/2003US20030207905 Method of treating pain using nalbuphine and opioid antagonists
11/06/2003US20030207904 Sensory nerve receptor agonist for topical delivery to the human lips, mouth, and to the anorectal area
11/06/2003US20030207903 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for sexual disfunction
11/06/2003US20030207902 Heterocyclic compounds useful as inhibitors of tyrosine kinases
11/06/2003US20030207901 Use in inhibiting specific intra- cellular signaling events induced by noxious or inflammatory stimuli; compounds have at least one hydroxyl-containing substituent bonded to core selected from xanthinyl, dioxotetrahydropteridine, phthalimide
11/06/2003US20030207900 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma
11/06/2003US20030207899 Heterocyclylaminomethyloxazo-lidinones as antibacterials
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207897 Selective inhibitors of cyclooxygenase-2
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207893 Antihistamines such as (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone, used as antiinflammatory, antiarthritic or bronchodilator agents and/or immunology modulators
11/06/2003US20030207892 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis
11/06/2003US20030207891 Mixtures of adrenergic blocking agents, phosphodiesterase inhibitors, dopaminergic agents, vasoactive intestinal peptides and optionally carriers, in the form of tablets; time release agents; sexual disorders
11/06/2003US20030207890 Administering serotonin receptor antagonists such as tandospirone, for prophylaxis of vision defects
11/06/2003US20030207888 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
11/06/2003US20030207887 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
11/06/2003US20030207886 Nitrogen compounds such as 5-nitro-2,3,6-trimethoxyquinoxaline used as photostable ultraviolet radiation filters in cosmetics and drugs; sunscreen agents
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/06/2003US20030207881 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207879 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy
11/06/2003US20030207878 Drugs used as angiogenesis inhibitors, vascular permeability or endothelial growth factor antagonists, for prophylaxis of cancer, diabetes, psoriasis, arthritis, autoimmune diseases, inflammation or scar formation
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207875 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
11/06/2003US20030207874 Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003US20030207870 Aryl ureas with angiogenisis inhibiting activity
11/06/2003US20030207869 Method for controlling pests, characterized in that at least one compound of the formula (I) according to claim 1 or a pesticide according to claim 7 is allowed to act on pests and/ or their habitat.
11/06/2003US20030207867 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
11/06/2003US20030207866 Drugs useful for the treatment of diseases or disorders of the central nervous system.
11/06/2003US20030207865 2-arylimino heterocycles, including 2- arylimino 1,3-thiazolidines, 2-arylimino-2,3,4,5 tetrahydro 1,3-thiazines, 2-arylimino-1,3 thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207863 Preventives and remedies for central nervous system diseases
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207860 Neuropeptide Y Y5 receptor antagonists
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207858 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.
11/06/2003US20030207856 Molecular chaperone inhibitor compositions and medical devices useful for the site specific delivery of molecular chaperones are disclosed. In one embodiment the medical device is a vascular stent coated with a molecular chaperone inhibitor
11/06/2003US20030207854 Methods of inhibiting progestin activity in a cell or in a subject in need of such inhibition, and methods of treating or preventing progestin-dependent conditions in a subject in need of such treatment or prevention and administering an
11/06/2003US20030207853 Sterol-modified hedgehog polypeptides and functional fragments thereof. Methods of identifying compositions which affect hedgehog activity based on inhibition of cholesterol modification of hedgehog protein are described. The method
11/06/2003US20030207852 Treating female sexual dysfunction are provided. A pharmaceutical composition formulated so as to contain a selected vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment.
11/06/2003US20030207851 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
11/06/2003US20030207850 Hormone replacement therapy
11/06/2003US20030207849 P38MAPK inhibitor and uses thereof
11/06/2003US20030207848 Vitamin D analog and a retinoid wherein: (a) the vitamin D analog is capable of binding a vitamin D receptor or being converted in vivo into a compound capable of binding a vitamin D receptor; and (b) the retinoid is selected from the group; restoring the natural color of gray hair
11/06/2003US20030207847 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
11/06/2003US20030207846 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003US20030207845 Treating an inflammatory disease by administering a phosphodiesterase 4 inhibitor in combiantion with an inhibitor of prostaglandin synthesis, NSAIDs being exemplary.
11/06/2003US20030207844 Methods, compositions, and kits, are provided for the use of nitric oxide synthase inhibitors to prevent and reduce wrinkles.
11/06/2003US20030207843 Treating viral infections caused by retroviruses. In a particular aspect of the invention, there are provided methods for treating viral infections caused by retroviruses which have developed resistance to antivirals, such as, for
11/06/2003US20030207841 Novel nucleoside and oligonucleotide analogues
11/06/2003US20030207834 The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
11/06/2003US20030207826 Nucleosides and other compounds to selectively modulate Th1 and Th2 responses relative to each other in the treatment of disease. In one aspect of the invention, administration of a nucleoside or other compound reduces the dosage at which a
11/06/2003US20030207825 Novel dinucleoside polyphosphates of general Formulae I, II and III, and formulations thereof which are selective ligands of the P2Y purinergic receptors. Applicants have discovered that dinucleoside polyphosphates of general Formulae I, II
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003US20030207822 Prescription that disperses a malignant tumor to decrease the size of the tumor or terminate the tumor. The local injection prescription is produced by dissolving an organic compound having a lactone nucleus in lower alcohol and water.
11/06/2003US20030207820 Prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis and treatment of bacterial infections
11/06/2003US20030207819 Utilizing 14- and 15-member macrolide antibiotics for the treatment of patients with connective tissue diseases. The methods of the invention provide for the administration to a patient of a therapeutically effective amount of a 14-member
11/06/2003US20030207818 7-Hydroxy chromones as potent antioxidants
11/06/2003US20030207817 Oil-in-polyhydric alcohol type warming base agent
11/06/2003US20030207816 Inducing or enhancing chondrogenesis in vivo or in vitro. The method is performed by exposing the cells in vitro or in vivo to an extracellular matrix comprising of type I collagen, type II collagen or a mixture of type I collagen or type II
11/06/2003US20030207815 Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
11/06/2003US20030207814 Novel guanidinyl derivatives
11/06/2003US20030207813 Retroviral protease inhibitor combinations
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207810 Method of treating malignancy associated hypercalcemia using active vitamin D analogues
11/06/2003US20030207794 Compounds which are alpha -halogenoacryloyl distamycin derivatives of formula (I) wherein R1 is a bromine or chlorine atom; R2 is a distamycin or distamycin-like framework as set forth in the specification; or a pharmaceutically acceptable
11/06/2003US20030207772 Warming and nonirritating lubricant compositions and method of comparing irritation
11/06/2003US20030207451 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207317 Novel nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207028 Substrate with a photocatalytic coating
11/06/2003US20030206980 Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
11/06/2003US20030206975 Compositions and methods of use for extracts of magnoliaceae plants
11/06/2003US20030206971 Aqueous acidulant part comprising an activator acid, a rheology modifier or a pseudoplastic thickener, a chlorine dioxide stable visual indicator system; alkali metal chlorite
11/06/2003US20030206970 Ophthalmic compositions containing galactomannan polymers and borate
11/06/2003US20030206969 Prenatal multivitamin/multimineral supplement
11/06/2003US20030206967 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time
11/06/2003US20030206966 Methods of inducing apoptosis and modulating metalloproteinases
11/06/2003US20030206963 Bone resorption suppressing agent
11/06/2003US20030206960 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/06/2003US20030206959 Method for preparing submicron particle suspensions
11/06/2003US20030206958 Chitosan biopolymer for the topical delivery of active agents
11/06/2003US20030206957 Orally administered medicament delivery systems
1 ... 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 ... 7860